Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.30503
Abstract: This survey study assesses changes in the therapeutic relationship between clinicians and parents of children with cancer over the first year of treatment.
read more here.
Keywords:
oncology;
relationship;
year treatment;
first year ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical immunology"
DOI: 10.1016/j.clim.2021.108859
Abstract: Changes on immune response of children with congenital toxoplasmosis (CT) regarding infection evolution and therapeutic intervention was addressed. Infants with CT presented increased counts of monocytes, CD3-CD16-CD56High, CD3+CD56+ and CD4+ T-cells 1-year after treatment onset…
read more here.
Keywords:
long term;
treatment onset;
year treatment;
cd3 cd16 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Modern rheumatology"
DOI: 10.1093/mr/roac093
Abstract: OBJECTIVES To evaluate the relevance of serum immunoglobulin G (IgG) titers against periodontopathic bacteria to predict the clinical response to one-year treatment with biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA) patients. METHODS Data…
read more here.
Keywords:
igg titers;
treatment;
year treatment;
one year ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Early Intervention in Psychiatry"
DOI: 10.1111/eip.13286
Abstract: To evaluate the 10‐year treatment outcomes and cost‐effectiveness of adolescents' mental health treatment initiated under the social network‐oriented open dialogue (OD) approach.
read more here.
Keywords:
open dialogue;
treatment;
year treatment;
treatment outcome ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0171070
Abstract: Introduction Non-adherence to disease-modifying antirheumatic drugs (DMARDs) is suspected to relate to health care costs. In this study we investigated this relation in the first year of treatment. Methods In a multi-center cohort study with…
read more here.
Keywords:
year treatment;
non adherence;
first year;
adherence ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "European Journal of Endocrinology"
DOI: 10.1530/eje-22-0160
Abstract: Objective To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in adult patients with Langerhans cell histiocytosis (LCH) and GH deficiency (GHD) enrolled in KIMS (Pfizer International Metabolic Database). Patients and methods…
read more here.
Keywords:
year;
langerhans cell;
patients langerhans;
year treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.987092
Abstract: Background Tolvaptan (TV) is the first vasopressin-receptor antagonist approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD). No publications report TV experience in real clinical practice during the first year of treatment. Methods…
read more here.
Keywords:
year;
dominant polycystic;
month;
year treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2019.00649
Abstract: Background: Use of antipsychotic medication is central in the treatment of psychotic disorders. However, there is limited knowledge about prescription practice of antipsychotics in the critical early phase of these disorders. Clinical guidelines recommend low…
read more here.
Keywords:
first year;
change;
treatment;
year ... See more keywords